pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
39
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
asundexian
Ischemic Stroke
Bayer AG
1
catalysts
Phase 3
centhaquine citrate
Hypovolemic Shock
Pharmazz Inc
1
catalysts
Phase 3
(balcinrenone + dapagliflozin)
(balcinrenone + dapagliflozin)
Congestive Heart Failure (Heart Failure)
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 3
← prev
page 1 of 2
next →
131
Pain
89
Neurology
1
CardiAMP
Myocardial Ischemia
$BCDA
BioCardia, Inc.
0
catalysts
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
0
catalysts
Phase 3
KPL-387
Pericarditis
$KNSA
Kiniksa Pharmaceuticals International, plc
0
catalysts
Phase 3
THRV-1268
Arrhythmias
$THRY
Thryv Holdings, Inc.
0
catalysts
Phase 3
abelacimab
abelacimab [INN]
Ischemic Stroke
$NVS
NOVARTIS AG
0
catalysts
Phase 3
apabetalone
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Bromodomain and extra-terminal motif (BET)
Resverlogix Corp
0
catalysts
Phase 3
ataciguat
ataciguat [INN]
Aortic Valve Stenosis
Kardigan Inc
0
catalysts
Phase 3
bucindolol hydrochloride
Gencaro (bucindolol hydrochloride)
Atrial Fibrillation
Adrenergic receptor alpha-1
Beta-1 adrenergic receptor
Genvara Biopharma Inc
0
catalysts
Phase 3
caficrestat
Cardiomyopathy
Aldo-keto reductase family 1 member B1
Biossil Inc
0
catalysts
Phase 3
dalcetrapib
Acute Coronary Syndrome
Cholesteryl ester transfer protein
DalCor Pharmaceuticals Inc
0
catalysts
Phase 3
danicamtiv
Dilated Cardiomyopathy
Cardiac myosin
Bristol-Myers Squibb Co
0
catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCX
Quince Therapeutics, Inc.
0
catalysts
Phase 3
efmirenpase alfa
efmirenpase alfa [INN]
Arterial Calcification
$BMRN
BIOMARIN PHARMACEUTICAL INC
0
catalysts
Phase 3
glenzocimab
Acute Ischemic Stroke
Platelet glycoprotein VI
Acticor Biotech SAS
0
catalysts
Phase 3
glyburide
Cirara (glyburide)
Diabetes
Sulfonylurea receptor 1, Kir6.2
$ETON
Eton Pharmaceuticals, Inc.
0
catalysts
Phase 3
lepodisiran sodium
Atherosclerosis
Eli Lilly and Co
0
catalysts
Phase 3
levosimendan
Pulmonary Hypertension
Phosphodiesterase 3
Troponin, cardiac muscle
$TENX
TENAX THERAPEUTICS, INC.
0
catalysts
Phase 3
milvexian
Acute Ischemic Stroke
Coagulation factor XI
Bristol-Myers Squibb Co
0
catalysts
Phase 3
nerinetide
Acute Ischemic Stroke
NoNO Inc
0
catalysts
Phase 3
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0
catalysts
Phase 3
olpasiran
Atherosclerosis
LPA mRNA
$AMGN
AMGEN INC
0
catalysts
Phase 3
psilocybin
Treatment Resistant Depression
5-hydroxytryptamine receptor 2A
$CMPS
COMPASS Pathways plc
0
catalysts
Phase 3
ralinepag XR
ralinepag
Pulmonary Arterial Hypertension
Prostacyclin receptor
$UTHR
UNITED THERAPEUTICS Corp
0
catalysts
Phase 3
rexlemestrocel-L
Revascor (rexlemestrocel-L)
Hypoplastic Left Heart Syndrome
$MESO
MESOBLAST LTD
0
catalysts
Phase 3
rinvecalinase alfa
Acute Ischemic Stroke
$DMAC
DiaMedica Therapeutics Inc.
0
catalysts
Phase 3
selatogrel
selatogrel [INN]
Myocardial Infarction
Idorsia Pharmaceutical Ltd
0
catalysts
Phase 3
seralutinib
Pulmonary Arterial Hypertension
Platelet-derived growth factor receptor
Macrophage colony-stimulating factor 1 receptor
$GOSS
Gossamer Bio, Inc.
0
catalysts
